lobbying_filings_raw: 340c9e77-b702-4fd3-9a54-3d82de3875b3

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API. Sortable columns (indexed): filing_type, client_name, filing_year, client_state, registrant_state, registrant_house_id, registrant_id. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
340c9e77-b702-4fd3-9a54-3d82de3875b3 MM 47108 CAPITOL SOLUTIONS 154449 AMGEN USA 2007 mid_year 2007-07-23T15:14:37-04:00 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/340c9e77-b702-4fd3-9a54-3d82de3875b3/", "filing_uuid": "340c9e77-b702-4fd3-9a54-3d82de3875b3", "filing_type": "MM", "filing_type_display": "Mid-Year Report", "filing_year": 2007, "filing_period": "mid_year", "filing_period_display": "Mid-Year (Jan 1 - Jun 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/340c9e77-b702-4fd3-9a54-3d82de3875b3/print/", "filing_document_content_type": "application/pdf", "income": "100000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": null, "dt_posted": "2007-07-23T15:14:37-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": null, "registrant_address_2": null, "registrant_different_address": null, "registrant_city": null, "registrant_state": null, "registrant_zip": null, "registrant": {"id": 47108, "url": "https://lda.senate.gov/api/v1/registrants/47108/", "house_registrant_id": 34430, "name": "CAPITOL SOLUTIONS", "description": "Government Relations Consultants", "address_1": "1800 Diagonal Road", "address_2": "Suite 600", "address_3": null, "address_4": null, "city": "Alexandria", "state": "VA", "state_display": "Virginia", "zip": "22314", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "DAVID TAYLOR", "contact_telephone": "+1 703-647-7537", "dt_updated": "2022-04-06T16:08:08.464604-04:00"}, "client": {"id": 154449, "url": "https://lda.senate.gov/api/v1/clients/154449/", "client_id": 1002842, "name": "AMGEN USA", "general_description": "Biotechnology Company", "client_government_entity": false, "client_self_select": false, "state": null, "state_display": null, "country": "", "country_display": "* Undetermined", "ppb_state": null, "ppb_state_display": null, "ppb_country": "", "ppb_country_display": "* Undetermined", "effective_date": "2007-07-23"}, "lobbying_activities": [{"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "H.R. 1908 a bill to provide for patent reform", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 19681, "prefix": null, "prefix_display": null, "first_name": "SARAH", "nickname": null, "middle_name": null, "last_name": "CURTIS", "suffix": null, "suffix_display": null}, "covered_position": "LEGISLATIVE ASSISTANT, REP. STRICKLAND", "new": null}, {"lobbyist": {"id": 40648, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": "C", "last_name": "TATE", "suffix": "jr", "suffix_display": "JR"}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "S.Con.Res. 21, The Budget Resolution, and its authorization levels for SCHIP, Medicare, and Medicaid", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 19681, "prefix": null, "prefix_display": null, "first_name": "SARAH", "nickname": null, "middle_name": null, "last_name": "CURTIS", "suffix": null, "suffix_display": null}, "covered_position": "LEGISLATIVE ASSISTANT, REP. STRICKLAND", "new": null}, {"lobbyist": {"id": 40648, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": "C", "last_name": "TATE", "suffix": "jr", "suffix_display": "JR"}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "H.R. 1956 To amend the Public Health Service Act to provide for the approval of similar biological products\nH.R. 1038 provide for the licensing of comparable and interchangeable biological products\n", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 19681, "prefix": null, "prefix_display": null, "first_name": "SARAH", "nickname": null, "middle_name": null, "last_name": "CURTIS", "suffix": null, "suffix_display": null}, "covered_position": "LEGISLATIVE ASSISTANT, REP. STRICKLAND", "new": null}, {"lobbyist": {"id": 40648, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": "C", "last_name": "TATE", "suffix": "jr", "suffix_display": "JR"}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Medicare reimbursement and coverage issues", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 19681, "prefix": null, "prefix_display": null, "first_name": "SARAH", "nickname": null, "middle_name": null, "last_name": "CURTIS", "suffix": null, "suffix_display": null}, "covered_position": "LEGISLATIVE ASSISTANT, REP. STRICKLAND", "new": null}, {"lobbyist": {"id": 40648, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": "C", "last_name": "TATE", "suffix": "jr", "suffix_display": "JR"}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "FOO", "general_issue_code_display": "Food Industry (safety, labeling, etc.)", "description": "The FDA\u2019s issuance of a black box warning for erythropoietin stimulating agents \nH.R. 2900 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the post-market authorities of the Food and Drug Administration with respect to the safety of drugs\n", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 19681, "prefix": null, "prefix_display": null, "first_name": "SARAH", "nickname": null, "middle_name": null, "last_name": "CURTIS", "suffix": null, "suffix_display": null}, "covered_position": "LEGISLATIVE ASSISTANT, REP. STRICKLAND", "new": null}, {"lobbyist": {"id": 40648, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": "C", "last_name": "TATE", "suffix": "jr", "suffix_display": "JR"}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} VA US 34430         Biotechnology Company 0 0         100000.0  

Links from other tables